|
Volumn 131, Issue 5, 2013, Pages 693-694
|
Effect of intravitreous anti vascular endothelial growth factor therapy on choroidal thickness in neovascular age-related macular degeneration using spectral-domain optical coherence tomography
b
USA
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BEVACIZUMAB;
RANIBIZUMAB;
ANTIANGIOGENIC THERAPY;
BRUCH MEMBRANE;
CHOROID;
CHOROIDAL THICKNESS;
DOSE RESPONSE;
DRUG EFFECT;
FOLLOW UP;
HUMAN;
LETTER;
NEOVASCULAR AGE RELATED MACULAR DEGENERATION;
PRIORITY JOURNAL;
RETINA MACULA AGE RELATED DEGENERATION;
SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY;
TREATMENT DURATION;
VISUAL ACUITY;
VISUAL SYSTEM PARAMETERS;
AGED;
AGED, 80 AND OVER;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
CHOROID;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INTRAVITREAL INJECTIONS;
MALE;
ORGAN SIZE;
RETREATMENT;
TOMOGRAPHY, OPTICAL COHERENCE;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VISUAL ACUITY;
WET MACULAR DEGENERATION;
|
EID: 84877702722
PISSN: 21686165
EISSN: None
Source Type: Journal
DOI: 10.1001/jamaophthalmol.2013.692 Document Type: Letter |
Times cited : (55)
|
References (6)
|